MedTrace Logo

Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting

NCT01876290 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2016-10-31

No results posted yet for this study

Summary

The investigators want to test if it is indicated to associate dexamethasone and ondansetron in obese patients having bariatric surgery under total intra-venous closed-loop anesthesia.

Conditions

  • Postoperative Nausea and Vomiting

Interventions

DRUG

Dexamethasone and Ondansetron

Comparison between Dexamethasone and Ondansetron and placebo in the prevention of postoperative Nausea and Vomiting

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Marc Fischler, MD · Hôpital Foch

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-01-31
Completion
2015-03-31

Countries

  • France

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01876290 on ClinicalTrials.gov